Pulmonx (LUNG) Depreciation & Amortization (CF) (2019 - 2025)

Pulmonx (LUNG) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $246000.0 in Q3 2025.

• On a quarterly basis, Depreciation & Amortization (CF) fell 34.57% year-over-year to $246000.0 in Q3 2025; TTM through Dec 2025 was $823000.0, a 44.88% decrease from a year earlier, with the FY2024 full-year figure at $1.5 million, down 3.55% from the prior year.
• Depreciation & Amortization (CF) for Q3 2025 stood at $246000.0, down from $299000.0 in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for LUNG reached as high as $437000.0 in Q1 2023 and fell as low as $141000.0 in Q1 2021.
• Historically, Depreciation & Amortization (CF) has averaged $328631.6 across 5 years, with a median of $374000.0 in 2021.
• Across the five-year window, Depreciation & Amortization (CF) surged 192.19% in 2021 and plunged 34.57% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $374000.0 in 2021, then increased by 3.21% to $386000.0 in 2022, then retreated by 25.65% to $287000.0 in 2023, then gained by 2.44% to $294000.0 in 2024, then retreated by 16.33% to $246000.0 in 2025.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $246000.0 in Q3 2025, $299000.0 in Q2 2025, and $278000.0 in Q1 2025.